| 000 | 03091nam a22003495i 4500 | ||
|---|---|---|---|
| 999 |
_c80337 _d80337 _x1 |
||
| 001 | 80337 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230207040301.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 140130s2014 xxk| s |||| 0|eng d | ||
| 020 | _a9781848827103 | ||
| 024 | 7 |
_a10.1007/978-1-84882-710-3 _2doi |
|
| 040 | _dES-MaUEC | ||
| 050 | 4 |
_aRC78.7.D53 _bM435 2014 |
|
| 245 | 1 | 0 |
_aMedical Imaging in Clinical Trials _cedited by Colin G. Miller, Joel Krasnow, Lawrence H. Schwartz. |
| 260 |
_aLondon _bSpringer International Publishing _c2014 |
||
| 300 |
_a1 recurso en línea (XVIII, 420 p.) _b111 ilustraciones, 57 ilustraciones en color |
||
| 336 |
_aTexto (visual) _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 520 | _aMedical Imaging in Clinical Trials is a key text in understanding the methodology and the metrics that are required in the field of medical imaging. As the pharmaceutical, biotech and medical device industries continue to identify ways to improve and speed up product development, medical imaging plays a more significant role. Medical Imaging in Clinical Trials aims to educate and provide a hands-on text for those involved in clinical trials and either new to medical imaging and having to assimilate it into clinical trials or requiring to understand the key differences between clinical trial imaging and “routineâ€{u08EC}inical imaging.Â{u0274} is targeted to those professionals involved in clinical trials at the clinical research site, pharmaceutical and medical device industries, and regulators.This is not the “how to imageâ€{u08AF}ok written for the radiologist or Radiological Technologist, but covers the critical aspects of clinical trial methodology that are important for these individuals to understand. This book addresses the ethics and radiation dosages of the different modalities, the end points commonly used for the different trial phases, the acquisition and analysis techniques, as well as the logistics management of medical imaging and the role of the central imaging lab or imaging core lab (ICL) which is now the standard requirement for clinical trials.Â{u01B5}rthermore this text delves into the details of the major therapeutic areas where medical imaging plays a primary or secondary efficacy or safety end point. | ||
| 650 | 7 |
_2embne _aDiagnóstico por imagen _9139972 |
|
| 700 | 1 |
_aMiller, Colin G _eeditor literario _988412 _0Local |
|
| 700 | 1 |
_aKrasnow, Joel _eeditor literario _988413 _0Local |
|
| 700 | 1 |
_aSchwartz, Lawrence H _eeditor literario _988414 _0Local |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-1-84882-710-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 907 |
_a.b12880905 _b10-10-17 _c11-11-15 |
||
| 942 |
_2lcc _cLE |
||
| 945 |
_aRC78.7.D53 M435 2014 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11560721 _z06-04-17 |
||
| 988 | _aEBSPRINGER | ||
| 998 |
_am _a_alco _a_vill _b11-11-15 _cm _dz _e- _feng _gxxk _h0 |
||